Nonetheless, the most common CPS types, HS2, HS4 complex, and HS1/44, represent more than a third of infections caused by C. jejuni globally,19 so a CPS-conjugated vaccine including those most prevalent CPS types and those regarding regional/economical variation would dramatically increase the proportion of risk population that might benefit from this prototype vaccine. This evidence concerns the gene CAD and infection.